Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex.
The latest crop of financings in the digital health category includes a sizeable $84 million round for Wellvana Health, with Genialis, ThoughtFull, and Mindset Health also